KIDNEY CANCER COALITION KIDNEYCAN (EIN 813352468) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Phone

2672237970

Tax Period

2023-01-01 to 2023-12-31

KIDNEY CANCER COALITION KIDNEYCAN, founded in 2016, is a community nonprofit in the Medical Research sector that reported $1.1M in total revenue in fiscal year 2023. Revenue surged 45% from the prior year, signaling strong growth momentum. Expenses of $1.1M left a modest 5% surplus.

Mission

OUR MISSION IS TO ACCELERATE CURES FOR KIDNEY CANCER BY: ADVOCATING FOR GOVERNMENT AND INDUSTRY FUNDING, FACILITATING COLLOBORATION ACROSS RESEARCH AND CLINICAL DISCIPLINES, AND OFFERING DIRECT FINANCIAL SUPPORT FOR RESEARCHERS WITH PROMISING IDEAS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $164,402

Program Service Revenue $954,026

Investment Income $22,838

Other Revenue $1,663

TOTAL REVENUE $1,142,929

Expense Breakdown

Grants Paid $50,000

Salaries & Benefits $281,120

Fundraising Expenses $0

Program Expenses $743,568

Other Expenses $757,009

TOTAL EXPENSES $1,088,129

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,142,929	$790,764	+0.4%
Expenses	$1,088,129	$643,368	+0.7%
Net Income	$54,800	$147,396	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$165,850

Total Directors

$165,850

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRYAN LEWIS	Director	40.00	Officer Director	$165,850	$0	$165,850
HOWARD MCCLURD	Director	0.00	Director	$0	$0	$0
GLENN HOSKIN	Director	0.00	Director	$0	$0	$0
HANS HAMMERS MD	Director	0.00	Director	$0	$0	$0
TONI CHOUEIRI MD	President	0.00	Director	$0	$0	$0
JOLEN JARRELL-MEADOWS	Director	0.00	Director	$0	$0	$0
STEVEN ZEIGER	Director	0.00	Director	$0	$0	$0
BRENDA KNAPP	Treasurer	20.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,142,929	$1,088,129	$1,517,881	$54,800
2022	$790,764	$643,368	$1,469,916	$147,396
2021	$1,038,387	$569,739	$1,227,198	$468,648
2020	$501,673	$294,744	$733,518	$206,929
2020	$501,673	$294,744	$733,518	$206,929
2019	$459,526	$413,803	$521,628	$45,723
2018	$619,565	$170,977	$479,475	$448,588

KIDNEY CANCER COALITION KIDNEYCAN